| scholarly article | Q13442814 |
| P2093 | author name string | Siba K Samal | |
| Subbiah Elankumaran | |||
| Zhuhui Huang | |||
| Abdul S Yunus | |||
| P2860 | cites work | Complete nucleotide sequence of Newcastle disease virus: evidence for the existence of a new genus within the subfamily Paramyxovirinae | Q31915388 |
| Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge | Q33783986 | ||
| Recombinant Newcastle disease virus as a vaccine vector | Q33850246 | ||
| Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens | Q34364428 | ||
| A summary of taxonomic changes recently approved by ICTV. | Q34526294 | ||
| Recovery of infectious respiratory syncytial virus expressing an additional, foreign gene. | Q35869559 | ||
| The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. | Q36651219 | ||
| Interferon gamma expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity | Q37184195 | ||
| Negative-strand RNA viruses: genetic engineering and applications | Q37249720 | ||
| Highly stable expression of a foreign gene from rabies virus vectors | Q37501426 | ||
| Rescue of a foreign gene by Sendai virus | Q37537871 | ||
| Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3' proximal first locus | Q38555148 | ||
| Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence | Q39594181 | ||
| A recombinant newcastle disease virus with low-level V protein expression is immunogenic and lacks pathogenicity for chicken embryos | Q39601258 | ||
| Newcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonist | Q39796662 | ||
| Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation | Q40735127 | ||
| Recombinant fowlpox virus vaccines for poultry | Q40795535 | ||
| Recombinant Semliki Forest virus vector exhibits potential for avian virus vaccine development | Q40811637 | ||
| Current and future recombinant viral vaccines for poultry. | Q40828785 | ||
| Genome replication of Newcastle disease virus: involvement of the rule-of-six | Q40847135 | ||
| Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope | Q40898990 | ||
| Development of a genetically marked recombinant rinderpest vaccine expressing green fluorescent protein | Q40899960 | ||
| Accommodation of foreign genes into the Sendai virus genome: sizes of inserted genes and viral replication | Q40934160 | ||
| Genetic manipulation of non-segmented negative-strand RNA viruses | Q40970649 | ||
| Recombinant viral vector vaccines for the veterinary use. | Q41506519 | ||
| Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins | Q42068721 | ||
| Sequence Analysis and Expression of the Host-protective Immunogen VP2 of a Variant Strain of Infectious Bursal Disease Virus Which Can Circumvent Vaccination with Standard Type I Strains | Q43922088 | ||
| Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens. | Q44172730 | ||
| Protection of chickens with or without maternal antibodies against both Marek's and Newcastle diseases by one-time vaccination with recombinant vaccine of Marek's disease virus type 1. | Q44419667 | ||
| Recovery of infectious SV5 from cloned DNA and expression of a foreign gene | Q44671408 | ||
| High-level expression of a foreign gene from the most 3'-proximal locus of a recombinant Newcastle disease virus | Q44881919 | ||
| Naturally occurring-neutralizing monoclonal antibody escape variants define the epidemiology of infectious bursal disease viruses in the United States | Q44896267 | ||
| Differentiation of infectious bursal disease viruses directly from infected tissues with neutralizing monoclonal antibodies: evidence of a major antigenic shift in recent field isolates. | Q44995251 | ||
| Group and strain-specific neutralization sites of infectious bursal disease virus defined with monoclonal antibodies | Q45058708 | ||
| Nucleotide sequences of the trailer, nucleocapsid protein gene and intergenic regions of Newcastle disease virus strain Beaudette C and completion of the entire genome sequence | Q45114178 | ||
| Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease | Q45755262 | ||
| Infectious bursal disease virus structural proteins expressed in a baculovirus recombinant confer protection in chickens | Q45775183 | ||
| A conformational immunogen on VP-2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens | Q45845818 | ||
| Comparative studies on structural and antigenic properties of two serotypes of infectious bursal disease virus | Q45847698 | ||
| Comparison of neutralizing antigens of recent isolates of infectious bursal disease virus | Q45854904 | ||
| Physicochemical and immunological characterization of recombinant host-protective antigen (VP2) of infectious bursal disease virus | Q45857478 | ||
| More bumps on the vaccine road. | Q45975323 | ||
| Recombinant Newcastle disease virus as a vaccine vector. | Q53654257 | ||
| Acute infectious bursal disease in poultry: Isolation and characterisation of a highly virulent strain | Q81742063 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virus | Q808 |
| Newcastle disease virus | Q327082 | ||
| Infectious bursal disease virus | Q707615 | ||
| Newcastle disease | Q11903425 | ||
| P304 | page(s) | 10054-10063 | |
| P577 | publication date | 2004-09-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. | |
| P478 | volume | 78 |
| Q35112976 | A host-restricted viral vector for antigen-specific immunization against Lyme disease pathogen. |
| Q42216746 | A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens |
| Q41435514 | A recombinant canine distemper virus expressing a modified rabies virus glycoprotein induces immune responses in mice |
| Q28261383 | Avian Paramyxovirus: A Brief Review |
| Q35790333 | Avian paramyxovirus serotypes 2-9 (APMV-2-9) vary in the ability to induce protective immunity in chickens against challenge with virulent Newcastle disease virus (APMV-1). |
| Q56514706 | Baculovirus Surface Display of Immunogenic Proteins for Vaccine Development |
| Q37639531 | Characterization of a recombinant Newcastle disease virus expressing the glycoprotein of bovine ephemeral fever virus |
| Q36933042 | Characterization of a recombinant Newcastle disease virus vaccine strain |
| Q39498475 | Chimeric rabies glycoprotein with a transmembrane domain and cytoplasmic tail from Newcastle disease virus fusion protein incorporates into the Newcastle disease virion at reduced levels |
| Q35689458 | Construction of Recombinant Baculoviruses Expressing Infectious Bursal Disease Virus Main Protective Antigen and Their Immune Effects on Chickens |
| Q38003693 | Current status of vaccines against infectious bursal disease |
| Q99578111 | Current status of virus-vectored vaccines against pathogens that affect poultry |
| Q36709731 | Development and registration of recombinant veterinary vaccines. The example of the canarypox vector platform |
| Q44910555 | Development of a multi-mimotope peptide as a vaccine immunogen for infectious bursal disease virus |
| Q36554577 | Economically important non-oncogenic immunosuppressive viral diseases of chicken--current status |
| Q43506938 | Effect of dietary supplementation of probiotic on the performance of F1 crossbred (Rhode Island red male × Fayoumi female) cockerels |
| Q40485622 | Effects of different promoters on the protective efficacy of recombinant Marek's disease virus type 1 expressing the VP2 gene of infectious bursal disease virus |
| Q36949597 | Engineered intermonomeric disulfide bonds in the globular domain of Newcastle disease virus hemagglutinin-neuraminidase protein: implications for the mechanism of fusion promotion |
| Q42212926 | Evaluation of avian paramyxovirus serotypes 2 to 10 as vaccine vectors in chickens previously immunized against Newcastle disease virus |
| Q41919169 | Expression of transgenes from newcastle disease virus with a segmented genome |
| Q45363233 | Generation and evaluation of a recombinant Newcastle disease virus expressing the glycoprotein (G) of avian metapneumovirus subgroup C as a bivalent vaccine in turkeys. |
| Q41325120 | Generation and evaluation of a recombinant genotype VII Newcastle disease virus expressing VP3 protein of Goose parvovirus as a bivalent vaccine in goslings |
| Q59356175 | Generation of a recombinant Newcastle disease virus expressing two foreign genes for use as a multivalent vaccine and gene therapy vector |
| Q33490614 | Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses |
| Q30363581 | Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus. |
| Q33848956 | Immunogenicity of recombinant Lactobacillus plantarum NC8 expressing goose parvovirus VP2 gene in BALB/c mice |
| Q46942447 | Induction of autoimmunity by immunization with hapten-modified hen egg lysozyme in hen egg lysozyme-transgenic mice |
| Q45359054 | Induction of protective immunity in chickens immunized with plant-made chimeric Bamboo mosaic virus particles expressing very virulent Infectious bursal disease virus antigen |
| Q93189780 | Infectious bursal disease virus in chickens: prevalence, impact, and management strategies |
| Q40368584 | Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus |
| Q36692742 | Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens |
| Q41929214 | Newcastle Disease Virus Vectored Bivalent Vaccine against Virulent Infectious Bursal Disease and Newcastle Disease of Chickens |
| Q26744220 | Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines |
| Q39056306 | Newcastle disease vaccines-A solved problem or a continuous challenge? |
| Q45326191 | Newcastle disease virus (NDV) recombinant expressing the hemagglutinin of H7N9 avian influenza virus protects chickens against NDV and highly pathogenic avian influenza A (H7N9) virus challenges |
| Q45342881 | Newcastle disease virus outbreaks in India: Time to revisit the vaccine type and strategies |
| Q40095159 | Newcastle disease virus vectored vaccines as bivalent or antigen delivery vaccines. |
| Q47117843 | Newcastle disease virus-based H5 influenza vaccine protects chickens from lethal challenge with a highly pathogenic H5N2 avian influenza virus |
| Q30357521 | Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. |
| Q35140435 | Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats |
| Q37535829 | Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer |
| Q38192846 | Newcastle disease virus: current status and our understanding |
| Q35139219 | Nonsegmented negative-strand viruses as vaccine vectors |
| Q47144787 | Opinion of the Scientific Panel on Animal Health and Welfare (AHAW) to review Newcastle disease focussing on vaccination worldwide in order to determine its optimal use for disease control purposes |
| Q37033299 | Optimization of human immunodeficiency virus gag expression by newcastle disease virus vectors for the induction of potent immune responses |
| Q36611663 | Protective efficacy of a recombinant Newcastle disease virus expressing glycoprotein of vesicular stomatitis virus in mice |
| Q45356216 | Protective immune responses of recombinant VP2 subunit antigen of infectious bursal disease virus in chickens |
| Q52717318 | Recombinant Newcastle disease virus (NDV) expressing Duck Tembusu virus (DTMUV) pre-membrane and envelope proteins protects ducks against DTMUV and NDV challenge. |
| Q24602728 | Recombinant Newcastle disease virus as a vaccine vector for cancer therapy |
| Q40273756 | Recombinant Newcastle disease virus expressing the infectious bronchitis virus S1 gene protects chickens against Newcastle disease virus and infectious bronchitis virus challenge |
| Q38559266 | Recombinant Newcastle disease virus-vectored vaccines against human and animal infectious diseases |
| Q30380898 | Recombinant vectors as influenza vaccines. |
| Q39590735 | Rescue of Newcastle disease virus from cloned cDNA using an RNA polymerase II promoter |
| Q40341670 | Rescue of a recombinant Newcastle disease virus strain R2B expressing green fluorescent protein |
| Q36190519 | Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response |
| Q35018292 | Retracted: Evaluation of the Replication, Pathogenicity, and Immunogenicity of Avian Paramyxovirus (APMV) Serotypes 2, 3, 4, 5, 7, and 9 in Rhesus Macaques |
| Q33828508 | Retracted: Experimental Infection of Mice with Avian Paramyxovirus Serotypes 1 to 9 |
| Q40200048 | Reverse Genetics of Newcastle Disease Virus |
| Q39877530 | Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector |
| Q42019718 | Role of the cytoplasmic tail amino acid sequences of Newcastle disease virus hemagglutinin-neuraminidase protein in virion incorporation, cell fusion, and pathogenicity |
| Q42092096 | Role of untranslated regions in regulation of gene expression, replication, and pathogenicity of Newcastle disease virus expressing green fluorescent protein |
| Q39868266 | Role of untranslated regions of the hemagglutinin-neuraminidase gene in replication and pathogenicity of newcastle disease virus |
| Q35076683 | Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity. |
| Q34979013 | The deletion of an extra six nucleotides in the 5' -untranslated region of the nucleoprotein gene of Newcastle disease virus NA-1 decreases virulence |
| Q30396985 | The effect of vaccination on the evolution and population dynamics of avian paramyxovirus-1. |
| Q44176217 | Virus-like particles of hepatitis B virus core protein containing five mimotopes of infectious bursal disease virus (IBDV) protect chickens against IBDV. |
| Q41230389 | gga-miR-9* inhibits IFN production in antiviral innate immunity by targeting interferon regulatory factor 2 to promote IBDV replication |
Search more.